Evidence map›Paper›PMID 28752371›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2017

Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers.

Vittoria Murro, Dario Pasquale Mucciolo, Ilaria Passerini, Simona Palchetti, Andrea Sodi, Gianni Virgili, Stanislao Rizzo

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Choroideremia Carriers: Dark-Adapted Perimetry and Retinal Structures.Investigative ophthalmology & visual science · 2022
    Article
  3. Choroidal Vascularity Index in CHM Carriers.Frontiers in ophthalmology · 2021
    Article
  4. Article
  5. Synonymous Variant in the CHM Gene Causes Aberrant Splicing in Choroideremia.Investigative ophthalmology & visual science · 2020
    Article
  6. Article
  7. Optical coherence tomography (OCT) features of cystoid spaces in choroideremia (CHM).Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2019
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Vittoria MurroDepartment of Translational Surgery and Medicine, Eye Clinic, University of Florence, Largo Brambilla, 3, 50134, Florence, Italy.
Dario Pasquale MuccioloDepartment of Translational Surgery and Medicine, Eye Clinic, University of Florence, Largo Brambilla, 3, 50134, Florence, Italy. dario.mucciolo@gmail.com.
Ilaria PasseriniDepartment of Genetic Diagnosis, Careggi Teaching Hospital, Florence, Italy.
Simona PalchettiDepartment of Genetic Diagnosis, Careggi Teaching Hospital, Florence, Italy.
Andrea SodiDepartment of Translational Surgery and Medicine, Eye Clinic, University of Florence, Largo Brambilla, 3, 50134, Florence, Italy.
Gianni VirgiliDepartment of Translational Surgery and Medicine, Eye Clinic, University of Florence, Largo Brambilla, 3, 50134, Florence, Italy.
Stanislao RizzoDepartment of Translational Surgery and Medicine, Eye Clinic, University of Florence, Largo Brambilla, 3, 50134, Florence, Italy.
University of Florence · ITAzienda Ospedaliero-Universitaria Careggi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe clinical and molecular characteristics in a group of Italian female choroideremia (CHM) carriers and report fundus patterns.

methodsWe retrospectively studied 11 female carriers belonging to six CHM families examined at the Regional Reference Center for Hereditary Retinal Degenerations at the Eye Clinic in Florence. We took into consideration patients with a comprehensive ophthalmological examination, fundus photography, optical coherence tomography (OCT), full field electro-retinography (ERG), and visual field (VF). All patients were screened for mutations of the CHM gene.

resultsFundus examination revealed retinal abnormalities in all female carriers (11/11) in the study; in particular four fundus patterns were identified: pattern A (RPE dystrophy involving only the peripheral retina), pattern B (RPE dystrophy involving the peripheral retina and the posterior pole with small hypo-pigmented RPE areas), pattern C (RPE dystrophy involving the peripheral retina and the posterior pole with small yellowish well-defined dots), and pattern D (RPE dystrophy involving the peripheral retina and the posterior pole with large hypo-pigmented RPE areas and well-defined yellowish dots). Pattern D was characterized by widespread macular subretinal drusenoid deposits (SDD). Half of the observed mutations were novel mutations. A genotype-phenotype correlation was not identified.

conclusionsRetinal dystrophy and SDD were detected in our female CHM carriers, and fundus patterns have been described in this study. The recognition of specific fundoscopic patterns may permit a correct diagnosis, an appropriate molecular investigation and genetic counseling.

Indexed as

MutationVisual AcuityAdaptor Proteins, Signal TransducingAdolescentAdultAgedChildChoroideremiaDNADNA Mutational AnalysisElectroretinographyFemaleFluorescein AngiographyFundus OculiHeterozygoteHumansAdaptor Proteins, Signal TransducingCHM protein, humanDNArab GTP-Binding ProteinsCarrierCHMChoroideremiaSubretinal drusenoid deposits

Identifiers

PMID28752371
OpenAlexW2741402549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.